Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

2.24USD
16 Oct 2018
Change (% chg)

$0.17 (+8.21%)
Prev Close
$2.07
Open
$2.13
Day's High
$2.32
Day's Low
$2.09
Volume
212,361
Avg. Vol
71,657
52-wk High
$2.65
52-wk Low
$0.69

Chart for

About

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system (CNS). Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II... (more)

Overall

Beta: -0.57
Market Cap(Mil.): $17.09
Shares Outstanding(Mil.): 10.75
Dividend: --
Yield (%): --

Financials

  VTGN.OQ Industry Sector
P/E (TTM): -- 30.95 32.69
EPS (TTM): -1.36 -- --
ROI: -245.77 14.77 14.32
ROE: -415.24 16.27 16.04

Competitors

Earnings vs. Estimates